A significant breakthrough in cancer investigation is arising with the use of nanobodies to reactivate damaged p53. This essential malignant inhibitor protein is frequently inactivated in many types of cancer, leading https://bookmarklayer.com/story21998452/nanobodies-reactivate-the-p53-protein-a-new-approach-for-tumor-treatment